Investors

Presentations & Videos

Presentations & Videos

2020

For investor-related information please contact Ronn Bechler at Market Eye
Ph: +61 (0) 400 009 774 E: ronn.bechler@marketeye.com.au

2022

See more
See more
https://www.youtube.com/watch?v=mvlllwtZdYg
Zelira Therapeutics Investor Presentation

Zelira Therapeutics Chairman Osagie Imasogie and Global CEO Dr Oludare Odumosu deliver a slide presentation and answer investor questions as part of a business update.

May 12, 2022
https://bcove.video/3rfBWM7
Zelira AGM Presentation January 2022

CEO Oludare Odumosu and Chairman Osagie Imasogie presentation at the Zelira AGM 2022

January 13, 2022
https://zeliratx.com/presentations/ZEL038 AGM Presentation FA.pdf
Zelira AGM Presentation January 2022

A Global Biopharmaceutical Company Developing and Marketing Clinically Validated Cannabinoid-Based Medicines

January 13, 2022

2021

See more
See more
https://zeliratx.com/presentations/Proactiveinvestors_AU_-_Zelira_Therapeutics_commercialisation_program_to_see_launch_of_suite_of_new_cannabinoid-based_prod.pdf
Zelira Therapeutics’ commercialisation program

Zelira to launch a suite of new cannabinoid-based products in FY22 – Proactive

September 1, 2021
https://www.youtube.com/watch?v=muhK--qz0hY
Channel 9 News Perth

Zelira Therapeutics and Curtin University partner on research of proprietary technology that demonstrates significant uptake of CBD into the brain

August 25, 2021
https://zeliratx.com/presentations/Zelira_Therapeutics-Cantor_Presentation-June_29_2021.pdf
Presentation at Cantor Fitzgerald International Cannabis Forum

Zelira Therapeutics Investor Slide Deck

June 29, 2021

2020

See more
See more
https://www.youtube.com/watch?v=to0cJZkeXNM
Proactive – Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

December 18, 2020
https://www.youtube.com/watch?v=eipQrkRxw_0
Proactive – Zelira Therapeutics and Emyria team up for ‘disruptive’ autism spectrum disorder trial

Some excerpt

November 9, 2020
https://clients3.weblink.com.au/pdf/ZLD/02296985.pdf
Investor Presentation – Non-Deal Roadshow
October 22, 2020

2019

See more
See more
https://www.youtube.com/watch?v=6LZLvRG9CeM
Proactive Interview – Zelira Therapeutics on its acquisition with Ilera
December 3, 2019
https://zeliratx.com/wp-content/uploads/2019/10/CFN-Media-Interviews-Zelda-Therapeutics-at-New-West-Summit2-Mp4-Video-1280x720-5-.mp4
CFN Media Interviews Zelda Therapeutics at New West Summit
October 24, 2019
https://zeliratx.com/wp-content/uploads/2019/10/Zelda-Therapeutics-Investor-Teleconference-10002468-161019.mp3
Zelda Therapeutics – Investor Teleconference, 16 October 2019
October 16, 2019

2018

See more
See more
https://www.youtube.com/watch?v=W4qXsc9jeok
Zelda Therapeutics poised to ‘value add al the way from clinical trails to the market’.
December 2, 2018
https://www.youtube.com/watch?v=W4qXsc9jeok
Zelda Therapeutics poised to ‘value add all the way from clinical trails to the market’
December 2, 2018
https://zeliratx.com/presentations/Investor_Presentation_Nondeal_RoadshowNOV2018.pdf
AGM Presentation – Non-deal Roadshow
November 30, 2018

2017

See more
See more
https://zeliratx.com/presentations/Preso_Nov2017.pdf
AGM Presentation
November 30, 2017
https://zeliratx.com/presentations/Preso_Feb2017.pdf
Investor Presentation
February 18, 2017

2016

See more
See more
https://zeliratx.com/presentations/Preso_Nov2016.pdf
Investor Presentation
November 30, 2016

2015

See more
See more
https://zeliratx.com/presentations/Preso_Dec2015.pdf
Investor Presentation
December 1, 2015

Contact Us

    Follow Zelira Therapeutics

    Subscribe

      Zelira Therapeutics
      Level 3, 101 St Georges Terrace, Perth WA 6000
      Phone +61 8 6558 0886

      Copyright © Zelira Therapeutics. All rights reserved. | Disclaimer.

      Start typing and press Enter to search

      View more
      Shopping Cart